Pyrocarbon Clinical Follow-up Study
PYC CFS
1 other identifier
observational
76
1 country
8
Brief Summary
The objective of this multi-center study is to collect medium and long-term data on the related clinical complications and functional outcomes of the Pyrocarbon Humeral Head to demonstrate safety and performance, in subjects from the Pyrocarbon IDE Study cohort. Data collected from this study will support post-market surveillance and MDR requirements as well provide the basis for peer-reviewed publications on mid- and long-term product performance and safety (five to ten years post-op).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2021
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2021
CompletedFirst Posted
Study publicly available on registry
September 20, 2021
CompletedStudy Start
First participant enrolled
October 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
February 10, 2026
February 1, 2026
5.6 years
September 9, 2021
February 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline to last follow-up visit in ASES scores
ASES Score = American Shoulder and Elbow Surgeons Score, 11 items with total score reported out of 100 measuring pain and activity of patient's evaluated shoulder where lower scores indicate more pain and less function
Follow-up visits through 10 years Post-Op
Secondary Outcomes (7)
Change from Baseline to last follow-up visit in Constant Murley scores
Follow-up visits through 10 years Post-Op
Change from Baseline to last follow-up visit in SANE scores
Follow-up visits through 10 years Post-Op
Change from Baseline to last follow-up visit in Subject Satisfaction scores
Follow-up visits through 10 years Post-Op
Change from Baseline to last follow-up visit in EQ-5D scores
Follow-up visits through 10 years Post-Op
Number of device associated and procedure associated adverse events.
Follow-up visits through 10 years Post-Op
- +2 more secondary outcomes
Interventions
Hemi Shoulder Arthroplasty using the Aequalis Pyrocarbon Humeral Head
Eligibility Criteria
Long-term follow-up of Pyrocarbon IDE patients.
You may qualify if:
- Subject in the Pyrocarbon IDE Study and has not had the device explanted.
- Patient informed, willing, and able to sign an informed consent form approved by IRB or EC
- Willing and able to comply with the requirements of the study protocol
You may not qualify if:
- Subjects who are not able to comply with the study procedures based on the judgment of the assessor will be excluded (e.g. cannot comprehend study questions, inability to keep scheduled assessment times)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
HCA HealthONE, LLC
Denver, Colorado, 80218, United States
Holy Cross Hospital
Fort Lauderdale, Florida, 33308, United States
Tulane University
New Orleans, Louisiana, 70112, United States
Southern Maryland Orthopedics
Waldorf, Maryland, 20602, United States
Allina Health Orthopedics
Minneapolis, Minnesota, 55407, United States
Missouri Orthopaedic Institute
Columbia, Missouri, 65211, United States
Duke University
Durham, North Carolina, 27705, United States
Southern Oregon Orthopedics
Medford, Oregon, 97504, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rebecca Gibson
Stryker Trauma & Extremities
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2021
First Posted
September 20, 2021
Study Start
October 27, 2021
Primary Completion (Estimated)
May 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
February 10, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share